Hot Pursuit     20-Apr-22
Alembic Pharma rises after receiving tentative approval for anti anginal drug
Alembic Pharmaceuticals gained 1.76% to Rs 761.95 after the drug maker received tentative approval from the US Food & Drug Administration (USFDA) for ivabradine tablets.
Ivabradine Tablets are indicated to reduce the risk of worsening heart failure in adult patients with stable, symptomatic chronic heart failure with left ventricular ejection fraction. The tablets are also indicated for the treatment of stable symptomatic heart failure due to dilated cardiomyopathy (DCM) in pediatric patients aged 6 months and older, who are in sinus rhythm with an elevated heart rate

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug, Corlanor Tablets of Amgen Inc. According to IQVIA, ivabradine tablets have an estimated market size of $102 million for twelve months ending December 2021.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

On a consolidated basis, the company reported a 39.7% fall in net profit to Rs 176.42 crore on a 3.2% fall in net sales to Rs 1,271.7 crore in Q3 FY22 over Q3 FY21.

Previous News
  Alembic Pharmaceuticals receives USFDA tentative approval for Ivosidenib Tablets
 ( Corporate News - 04-Jul-24   16:11 )
  Alembic Pharma hits record high on USFDA nod for anti psychotic drug
 ( Hot Pursuit - 24-Jul-24   14:43 )
  Alembic Pharma Q1 PAT rises 12% YoY to Rs 135 cr
 ( Hot Pursuit - 08-Aug-24   15:48 )
  Alembic Pharma gets US FDA nod for anticoagulant Dabigatran
 ( Hot Pursuit - 13-Aug-24   13:46 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Volumes jump at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 21-Feb-23   11:00 )
  Alembic Pharma gets USFDA nod for Docetaxel injection
 ( Hot Pursuit - 01-Mar-23   11:59 )
  Alembic Pharmaceuticals receives USFDA approval for Docetaxel Injection
 ( Corporate News - 01-Mar-23   15:51 )
  Alembic receives USFDA approval for Fulvestrant Injection
 ( Corporate News - 26-Dec-22   09:10 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
Other Stories
  Volumes jump at Just Dial Ltd counter
  03-Oct-24   11:00
  Yes Bank's loan book rises to Rs 2.36 lakh crore in Q2 FY25; deposits up over 18% YoY
  03-Oct-24   10:46
  KRN Heat Exchanger makes stellar debut
  03-Oct-24   10:31
  Maruti Suzuki total sales rises to 1,84,727 units in Sep’24
  03-Oct-24   10:12
  Metal shares gain
  03-Oct-24   10:00
  Basic materials shares gain
  03-Oct-24   10:00
  Telecom shares rise
  03-Oct-24   10:00
  JSW Steel Ltd Spikes 1.87%
  03-Oct-24   09:30
  Eicher Motors Ltd Falls 3.14%, BSE Auto index Drops 2.14%
  03-Oct-24   09:30
  Adani Ports records 14% YoY growth in Sept'24 cargo volumes
  03-Oct-24   09:29
Back Top